Porous chitosan scaffold containing microspheres loaded with transforming growth factor-β1:: Implications for cartilage tissue engineering

被引:234
作者
Kim, SE [1 ]
Park, JH [1 ]
Cho, YW [1 ]
Chung, H [1 ]
Jeong, SY [1 ]
Lee, EB [1 ]
Kwon, IC [1 ]
机构
[1] Korea Inst Sci & Technol, Ctr Biomed Res, Seoul 136791, South Korea
关键词
chitosan; microsphere; transforming growth factor beta 1; sustained release; chondrocyte; articular cartilage;
D O I
10.1016/S0168-3659(03)00274-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Damaged articular cartilage, caused by traumatic injury or degenerative diseases, has a limited regenerative capacity and frequently leads to the onset of osteoarthritis. As a promising strategy for the successful regeneration of long-lasting hyaline cartilage, tissue engineering has received increasing recognition. In this study, we attempted to design a novel type of porous chitosan scaffold, containing transforming growth factor-beta1 (TGF-beta1), to enhance chondrogenesis. First, to achieve a sustained release of TGF-beta1, chitosan microspheres loaded with TGF-beta1 (MS-TGFs) were prepared by the emulsion method, in the presence of tripolyphosphate; with an identical manner, microspheres loaded with BSA, a model protein, were also prepared. Both microspheres containing TGF-beta1 and BSA had spherical shapes with a size ranging from 0.2 to 1.5 mum. From the release experiments, it was found that both proteins were slowly released from the microspheres over 5 days in a PBS solution (pH 7.4), in which the release rate of TGF-beta1 was much lower than that of BSA. Second, MS-TGFs were seeded onto the porous chitosan scaffold, prepared by the freeze-drying method, to observe the effect on the proliferation and differentiation of chondrocytes. It was obviously demonstrated from in vitro tests that, compared to the scaffold without MS-TGF, the scaffold containing MS-TGF significantly augments the cell proliferation and production of extracellular matrix, indicating the role of TGF-beta1 released from the microspheres. These results suggest that the chitosan scaffold containing MS-TGF possesses a promising potential as an implant to treat cartilage defects. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:365 / 374
页数:10
相关论文
共 49 条
[1]  
Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO
[2]  
2-M
[3]  
ANDRADE JD, 1985, SURFACE INTERFACIAL, V2, P10
[4]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[5]   Preparation of alginate/galactosylated chitosan scaffold for hepatocyte attachment [J].
Chung, TW ;
Yang, J ;
Akaike, T ;
Cho, KY ;
Nah, JW ;
Kim, SI ;
Cho, CS .
BIOMATERIALS, 2002, 23 (14) :2827-2834
[6]   Chitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte complexes: biological properties [J].
Denuziere, A ;
Ferrier, D ;
Damour, O ;
Domard, A .
BIOMATERIALS, 1998, 19 (14) :1275-1285
[7]   NEOCARTILAGE FORMATION INVITRO AND INVIVO USING CELLS CULTURED ON SYNTHETIC BIODEGRADABLE POLYMERS [J].
FREED, LE ;
MARQUIS, JC ;
NOHRIA, A ;
EMMANUAL, J ;
MIKOS, AG ;
LANGER, R .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1993, 27 (01) :11-23
[8]   Treatment of articular cartilage defects of the knee with autologous chondrocyte implantation [J].
Gillogly, SD ;
Voight, M ;
Blackburn, T .
JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY, 1998, 28 (04) :241-251
[9]   Engineered cartilage, bone, joints, and menisci - Potential for temporomandibular joint reconstruction [J].
Glowacki, J .
CELLS TISSUES ORGANS, 2001, 169 (03) :302-308
[10]  
GREEN WT, 1977, CLIN ORTHOP RELAT R, P237